Related Experiment Video
Updated: Jun 16, 2026

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells
Published on: August 23, 2014
Gene targeting using the human Nalm-6 pre-B cell line
Noritaka Adachi1, Hitoshi Nishijima, Kei-ichi Shibahara
1International Graduate School of Arts and Sciences, Yokohama City University, Kanazawa-ku, Yokohama, Kanagawa, Japan.
Gene targeting in human cells is challenging due to low efficiency. This review details a protocol using Nalm-6 cells for efficient gene knockout and conditional gene depletion, aiding human gene function studies.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Gene targeting via homologous recombination is crucial for studying gene function.
- Its efficiency is low in human somatic cells, limiting its application.
- Nalm-6 cells offer a promising model for efficient gene targeting.
Purpose of the Study:
- To introduce a strategy for gene targeting in human Nalm-6 cells.
- To enable the generation of null alleles and tetracycline-inducible conditional gene knockouts.
- To facilitate the study of human gene function.
Main Methods:
- Utilizing homologous recombination for gene targeting.
- Employing the Nalm-6 human pre-B cell line for efficient targeting.
- Implementing a tetracycline-regulated gene depletion (Tet-Off) system.
Main Results:
- Demonstrated efficient gene targeting in Nalm-6 cells.
- Established a protocol for generating null alleles.
- Enabled tetracycline-inducible conditional gene knockout.
Conclusions:
- Gene targeting in Nalm-6 cells is an efficient method for studying human gene function.
- This approach overcomes the limitations of low targeting efficiency in other human somatic cells.
- The described protocol offers a valuable tool for researchers in various fields.
More Related Videos
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023